Cited by 236Gut microbiota and healthAlzheimer's disease research and treatmentsNeurogenesis and neuroplasticity mechanisms

Microbiota from Alzheimer’s patients induce deficits in cognition and hippocampal neurogenesis

Open access
Grabrucker, Stefanie, Marizzoni, Moira, Silajdžić, Edina, Lopizzo, Nicola, Mombelli, Elisa, Nicolas, Sarah, Dohm-Hansen, Sebastian, Scassellati, Catia +11 more·2023·Brain

Abstract

Alzheimer’s disease is a complex neurodegenerative disorder leading to a decline in cognitive function and mental health. Recent research has positioned the gut microbiota as an important susceptibility factor in Alzheimer’s disease by showing specific alterations in the gut microbiome composition of Alzheimer’s patients and in rodent models. However, it is unknown whether gut microbiota alterations are causal in the manifestation of Alzheimer’s symptoms. To understand the involvement of Alzheimer’s patient gut microbiota in host physiology and behaviour, we transplanted faecal microbiota from Alzheimer’s patients and age-matched healthy controls into microbiota-depleted young adult rats. We found impairments in behaviours reliant on adult hippocampal neurogenesis, an essential process for certain memory functions and mood, resulting from Alzheimer’s patient transplants. Notably, the severity of impairments correlated with clinical cognitive scores in donor patients. Discrete changes in the rat caecal and hippocampal metabolome were also evident. As hippocampal neurogenesis cannot be measured in living humans but is modulated by the circulatory systemic environment, we assessed the impact of the Alzheimer’s systemic environment on proxy neurogenesis readouts. Serum from Alzheimer’s patients decreased neurogenesis in human cells in vitro and were associated with cognitive scores and key microbial genera. Our findings reveal for the first time, that Alzheimer’s symptoms can be transferred to a healthy young organism via the gut microbiota, confirming a causal role of gut microbiota in Alzheimer’s disease, and highlight hippocampal neurogenesis as a converging central cellular process regulating systemic circulatory and gut-mediated factors in Alzheimer’s.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/brain/awad303

Cites

127 of 127 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Fecal microbiota transplantation studies demonstrate that AD pathological features can be largely transferred to a healthy host via the gut microbiota, indicating a possible causal role of commensal microbes in AD.

    “Fecal microbiota transplantation studies demonstrate that AD pathological features can be largely transferred to a healthy host via the gut microbiota, indicating a possible causal role of commensal microbes in AD.”

    From What would it take to prove that a chronic infection is a causal agent in Alzheimer’s disease? (2025) · cites this paper as [98]

    The Discussion reports that microbiota from Alzheimer’s patients transferred cognitive and neurogenic alterations to healthy young rats and describes this as evidence for a causal role of gut microbiota. But the Results report no amyloid plaque deposition in the recipient rats, so the broader assertion that AD pathological features were largely transferred overstates what the study showed. Page numbers are unavailable in our copy. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Reduced SCFA-producing species and SCFA levels are reported in individuals with mild cognitive impairment and AD patients.

    “Several studies have reported reduced SCFAs-producing species and SCFA levels in individuals with mild cognitive impairment (MCI) and AD patients.292–295”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Grabrucker, S., Marizzoni, M., Silajdžić, E., Lopizzo, N., Mombelli, E., Nicolas, S., Dohm-Hansen, S., Scassellati, C., Moretti, D. V., Rosa, M., Hoffmann, K., Cryan, J. F., O’Leary, O. F., English, J. A., Lavelle, A., O’Neill, C., Thuret, S., Cattaneo, A., & Nolan, Y. M.
Affiliations
  • University College Cork (IE)
  • Centro San Giovanni di Dio Fatebenefratelli (IT)
  • King's College London (GB)
  • University of Milan (IT)
Corresponding author
Nolan, Yvonne M
Venue
Brain
Published
2023-10-18
Volume
146
Issue
12
Pages
4916-4934
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W4387729030
Cited by
236
References
127
Citations by year
2026: 55 · 2025: 103 · 2024: 71 · 2023: 7
FWCI
21.03
Type
journal article
Language
en
Open access
Locations
  • Brain (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
  • Research Portal (King's College London) (submittedVersion, cc-by-nc)
Funders
  • Network of Centres of Excellence in Neurodegeneration (SFI 17/COEN/3475, SFI 19/FFP/6820)
  • Italian Ministry of Health
  • Medical Research Council (MR/S00484X/1)
  • APC Microbiome Ireland
  • SFI
  • Irish Government’s National Development Plan (12/RC/2273)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
Keywords
Alzheimer's disease, gut microbiota, fecal microbiota transplantation, hippocampal neurogenesis, cognitive impairment, microbial genera, gut-brain axis, neurodegeneration
MeSH terms
Gastrointestinal Microbiome, Alzheimer Disease, Animals, Cognition, Hippocampus, Humans, Rats, Neurogenesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review